These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 33098770)
121. Future Perspectives in Oxidative Stress in Trisomy 13 and 18 Evaluation. Buczyńska A; Sidorkiewicz I; Hameed A; Krętowski AJ; Zbucka-Krętowska M J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407395 [TBL] [Abstract][Full Text] [Related]
122. Apigenin Alleviates Intervertebral Disc Degeneration Xie C; Shi Y; Chen Z; Zhou X; Luo P; Hong C; Tian N; Wu Y; Zhou Y; Lin Y; Dou H; Wu A; Huang Q; Zhang X; Wang X Front Cell Dev Biol; 2021; 9():787278. PubMed ID: 35096819 [TBL] [Abstract][Full Text] [Related]
123. Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone. Valenti D; Stagni F; Emili M; Guidi S; Bartesaghi R; Vacca RA Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052567 [TBL] [Abstract][Full Text] [Related]
124. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome. Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516 [TBL] [Abstract][Full Text] [Related]
125. Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules. Lanzillotta C; Di Domenico F Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33670211 [TBL] [Abstract][Full Text] [Related]
126. Down syndrome is an oxidative phosphorylation disorder. Bayona-Bafaluy MP; Garrido-Pérez N; Meade P; Iglesias E; Jiménez-Salvador I; Montoya J; Martínez-Cué C; Ruiz-Pesini E Redox Biol; 2021 May; 41():101871. PubMed ID: 33540295 [TBL] [Abstract][Full Text] [Related]
127. Significant Effects of Maternal Diet During Pregnancy on the Murine Fetal Brain Transcriptome and Offspring Behavior. Edlow AG; Guedj F; Sverdlov D; Pennings JLA; Bianchi DW Front Neurosci; 2019; 13():1335. PubMed ID: 31920502 [TBL] [Abstract][Full Text] [Related]
128. Prenatal treatment of Down syndrome: a reality? Guedj F; Bianchi DW; Delabar JM Curr Opin Obstet Gynecol; 2014 Apr; 26(2):92-103. PubMed ID: 24573065 [TBL] [Abstract][Full Text] [Related]
129. [Is Neuron-Vascular Communication Disturbed in the Delayed Prenatal Brain Development of a Mouse Model of Down Syndrome?]. Ishihara K Yakugaku Zasshi; 2021; 141(3):369-373. PubMed ID: 33642505 [TBL] [Abstract][Full Text] [Related]
130. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model. Guedj F; Siegel AE; Pennings JLA; Alsebaa F; Massingham LJ; Tantravahi U; Bianchi DW Am J Hum Genet; 2020 Nov; 107(5):911-931. PubMed ID: 33098770 [TBL] [Abstract][Full Text] [Related]
131. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome. Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957 [TBL] [Abstract][Full Text] [Related]
132. The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome. Guedj F; Pennings JL; Ferres MA; Graham LC; Wick HC; Miczek KA; Slonim DK; Bianchi DW Am J Med Genet A; 2015 Sep; 167A(9):1993-2008. PubMed ID: 25975229 [TBL] [Abstract][Full Text] [Related]
133. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells. Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301 [TBL] [Abstract][Full Text] [Related]
134. Perturbation of the immune cells and prenatal neurogenesis by the triplication of the Erg gene in mouse models of Down syndrome. Ishihara K; Shimizu R; Takata K; Kawashita E; Amano K; Shimohata A; Low D; Nabe T; Sago H; Alexander WS; Ginhoux F; Yamakawa K; Akiba S Brain Pathol; 2020 Jan; 30(1):75-91. PubMed ID: 31206867 [TBL] [Abstract][Full Text] [Related]
135. An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome. Guedj F; Pennings JL; Massingham LJ; Wick HC; Siegel AE; Tantravahi U; Bianchi DW Sci Rep; 2016 Sep; 6():32353. PubMed ID: 27586445 [TBL] [Abstract][Full Text] [Related]
136. Retraction notice to "Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced Parkinsonism in mice" [Neuropharmacology, 86 (2014) 192-202]. Patil SP; Jain PD; Sancheti JS; Ghumatkar PJ; Tambe R; Sathaye S Neuropharmacology; 2022 Jan; 202():108876. PubMed ID: 34763895 [No Abstract] [Full Text] [Related]